Tag: Zydus Pharmaceuticals

Zydus Lifesciences gets FDA tentative approval for Invokamet generic

businessnewstoday- February 22, 2023

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has been granted tentative approval for Canagliflozin and Metformin Hydrochloride Tablets, 50mg/500mg, 50mg/1,000mg, 150mg/500mg, and 150mg/1,000mg ... Read More

Zydus Lifesciences gets FDA tentative approval for Levothyroxine Sodium generic

businessnewstoday- November 28, 2022

Zydus Lifesciences (previously Cadila Healthcare), through its US subsidiary Zydus Pharmaceuticals (USA), has secured tentative approval for Levothyroxine Sodium for injection, 100 mcg/vial, 200 mcg/vial, ... Read More

Zydus Lifesciences gets FDA final approval for Brivaracetam generic

businessnewstoday- October 6, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has bagged final approval to market Brivaracetam Tablets USP 10 mg, 25 ... Read More

Zydus Lifesciences gets final FDA approval for Mirabegron generic

businessnewstoday- October 4, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its US subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) ... Read More

Zydus Lifesciences gets tentative FDA approval for Sugammadex generic

pallavi123- September 18, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary Zydus Pharmaceuticals (USA) has secured tentative approval for Sugammadex Injection USP 200 mg/2 mL (100 ... Read More

Zydus Lifesciences bags FDA approval for Cariprazine generic

pallavi123- September 17, 2022

Zydus Lifesciences (previously Cadila Healthcare) said that its American subsidiary — Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration ... Read More

Zydus gets FDA approval for COPD drug Roflumilast Tablets

pallavi123- February 14, 2022

Zydus Group said that its subsidiary Zydus Pharmaceuticals (USA) has secured final approval from the US Food and Drug Administration (FDA) to market Roflumilast Tablets ... Read More

Zydus Cadila partners with CHEMI to launch Enoxaparin Sodium Injection in US

pallavi123- August 21, 2021

Zydus Pharmaceuticals Inc, USA, a fully-owned subsidiary of Cadila Healthcare (Zydus Cadila), has signed a license and supply deal with CHEMI SpA for launching the ... Read More